AI assistant
Sending…
Immunome Inc. — Director's Dealing 2025
Dec 31, 2025
32238_dirs_2025-12-30_1e48fee9-5d3a-4426-a957-abd5c6eef3ac.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Immunome Inc. (IMNM)
CIK: 0001472012
Period of Report: 2025-12-30
Reporting Person: SIEGALL CLAY B (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-12-30 | Common Stock | P | 4729 | $21.15 | Acquired | 665254 | Direct |
More from Immunome Inc.
Annual Report
2026
Apr 24
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 24
Regulatory Filings
2026
Mar 20
Annual Report
2026
Mar 3
Regulatory Filings
2026
Mar 3
Major Shareholding Notification
2026
Feb 17
Director's Dealing
2025
Dec 23
Major Shareholding Notification
2025
Dec 23
Director's Dealing
2025
Dec 22